Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management

Transfusion

Volumn 48, Issue 9, 2008, Pages 1833-1841

  Kiely, Philip ^a   Thomas, Brian ^a   Kebede, Mekonnen ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; CHEMOLUMINESCENCE; DONOR SELECTION; FOLLOW UP; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOASSAY; LONG TERM CARE; MAJOR CLINICAL STUDY; PATIENT CARE; VIRUS DETECTION;

BLOOD DONORS; CHEMILUMINESCENT MEASUREMENTS; DELTARETROVIRUS INFECTIONS; FALSE POSITIVE REACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOASSAY; TIME FACTORS;

EID: 50849119381     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01760.x     Document Type: Article

References (40)

1. Sakaugawa H, Nakasome H, Nakayoshi T, Kinjo F, Saito A, Yakabi S, Zukeran H, Miyagi Y, Taira R, Koja K, Uezu T, Kina M, Omine K. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area. J Med Virol 1995 46 : 334 8.
2. Allain JP, Kitchen A, Aloysius S, Reeves J, Petrik J, Barbara JA, Williamson LM. Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening immunoassays. Transfusion 1996 36 : 401 5.
3. Caspari G, Gerlich WH, Beyer J, Schmitt H. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors. Arch Virol 1997 142 : 473 9.
4. Ownby HE, Korelitz JJ, Busch MP, Williams AE, Kleinman SH, Gilcher RO, Nourjah P. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Transfusion 1997 37 : 199 205.
5. Dow BC. "Noise" in microbiological screening assays. Transfus Med 2000 10 : 97 106.
6. Kiely P, Wilson D. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management. Transfusion 2000 40 : 580 4.
7. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L. Improved efficiency of national HIV, HCV and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 2003 43 : 226 34.
8. Sharma UK, Stramer SL, Wright DJ, Glynn SA, Hermansen S, Schreiber GB, Kleinman SH, Busch MP. Impact of changes in viral marker screening assays. Transfusion 2003 43 : 202 14.
9. Kiely P, Stewart Y, Castro L. Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management. Transfusion 2003 43 : 584 90.
10. Dodd RY, Houlihan K, Lamberson HV. The specificity of enzyme immunoassays for antibodies to human immunodeficiency virus: impact on record and donor management [letter]. Transfusion 1993 33 : 693.
11. Atrah HI, Parry JV, Gough D, Tosswill J, Ala FA. Management of blood donors whose donations are repeatedly falsely positive by the HIV antibody screening test. J Clin Pathol 1995 48 : 865 7.
12. Bar-Shany S, Green MS, Shinar E. False positive tests for anti-hepatitis C antibodies and the problem of notifying blood donors. Int J Epidemiol 1996 25 : 674 8.
13. Reesink HW, Engelfriet CP. What are the consequences of indeterminate results in confirmatory tests for antibodies against transmissible viruses (International Forum)? Vox Sang 1997 73 : 97 104.
14. Busch MP. To thy (reactive) donors be true! [editorial]. Transfusion 1997 37 : 117 20.
15. Dodd RY, Stramer SL. Indeterminate results in blood donor testing: what you don't know can hurt you. Transfus Med Rev 2000 14 : 151 60.
16. Kiely P, Wood E. Can we improve the management of blood donors with non-specific reactivity in viral screening and confirmatory assays? Transfus Med Rev 2005 19 : 58 65.
17. Kleinman S, Wang B, Wu Y, Glynn SA, Williams A, Nass C, Ownby H, Busch MP. The donor notification process from the donor's perspective. Transfusion 2004 44 : 658 66.
18. Tynell E, Norda R, Ekermo B, Sanner M, Anderson S, Bjorkman A. False-reactive microbiologic screening test results in Swedish blood donors - how big is the problem? A survey among blood centers and deferred donors. Transfusion 2007 47 : 80 9.
19. Piliavin JA. Temporary deferral and donor return. Transfusion 1987 27 : 199 200.
20. Halperin D, Baetens J, Newman B. The effect of short-term, temporary deferral on future blood donation. Transfusion 1998 38 : 181 3.
21. Katz LM, Kabat A. Return behaviour of blood donors after expiration of a 1-year malarial travel deferral [letter]. Transfusion 2007 47 : 356 7.
22. Newman BH, Roth AJ. Estimating the probability of a blood donation adverse event based on 1000 interviewed whole-blood donors. Transfusion 2005 45 : 1715 21.
23. Newman BH, Newman DT, Ahmand R, Roth AJ. The effect of whole-blood donor adverse events on blood donor return rates. Transfusion 2006 46 : 1374 79.
24. Howell DR, Moore C. How many donors with transfusion microbiology false positive results return to give samples for re-entry [abstract]. Transfus Med 2006 16 Suppl 1 : 49.
25. Moore MC, Howell DR, Barbara JA. Donors whose blood reacts falsely positive in transfusion microbiology screening assays need not be lost to transfusion. Transfus Med 2007 17 : 55 9.
26. Barbara J, Ramskill S, Perry K, Parry J, Nightingale M. The National Blood Service (England) approach to evaluation of kits for detecting infectious agents. Transfus Med Rev 2007 21 : 147 58.
27. Simonsen L, Buffington J, Shapiro CN, Holman R, Strine TW, Grossman BJ, Williams AE, Schonberger B. Multiple false reactions in viral antibody screening assays after influenza vaccination. Am J Epidemiol 1995 141 : 1089 96.
28. Pearlman ES, Ballas SK. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch Pathol Lab Med 1994 118 : 805 6.
29. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol 2006 44 : 3021 4.
30. Tsao K-C, Chen G-W, Huang C-G, Huang Y-L, Lin J-Y, Keng M-C, Sun C-F, Shih S-R. False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome. J Med Virol 2005 77 : 331 6.
31. Schupbach J, Baumgartner A, Tomasik Z. HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal donors. Int J Cancer 1988 42 : 857 62.
32. Vardinon N, Yust I, Katz O, Iaina A, Katzir Z, Modai D, Burke M. Anti-HIV indeterminate Western blot in dialysis patients: a long term follow-up. Am J Kidney Dis 1999 34 : 146 9.
33. Agha S, El-Mashad N, El-Malky M, El-Shony H, El-Sherif MZ, El-Hasan MA, Tanaka Y, Mizokami M. Prevalence of low positive anti-HCV antibodies in blood donors: Schistosoma mansoni co-infection and possible role of autoantibodies. Microbiol Immunol 2006 50 : 447 52.
34. William JH, Hill HR, Martins TB, Kaskowski TD, Ashwood ER, Litwin CM. Multiplex analysis of heterophil antibody in patients with indeterminate HIV immunoassay results. Am J Clin Pathol 2001 115 : 764 9.
35. Bouillon M, Aubin E, Roberge C, Bazin R, Lemieux R. Reduced frequency of blood donors with false-positive HIV-1 and -2 antibody EIA reactivity after elution of low- affinity non-specific natural antibodies. Transfusion 2002 42 : 1046 52.
36. Stramer SL, Dilender MJ, Pendy LM, Holzer TJ. False positive EIA reactivity in multiple blood bank screening assays is due to non-specific binding of IgM [abstract]. Transfusion 1992 32 Suppl : 30s.
37. Bazin R, Aubin E, Roberge C, Lemieux R. Molecular basis for the false positive reactions in HIV-1/2 enzyme immunoassays [abstract]. Transfusion 2001 41 Suppl : 79s.
38. Hager JA, Bennett S, Toler O. Variations in initial and repeat reactive rates found in kit lots used for blood donor infectious disease testing [abstract]. Transfusion 2007 47 Suppl : 125A.
39. Kostelac S, Kiely P. Abbott PRISM HIV-1/HIV-2 and HIV O plus chemiluminescent immunoassays (ChLIA): comparison of biological false reactive (BFR) populations [abstract]. 18th NRL Workshop on Serology, Melbourne, Australia, August 24-6, 2001.
40. Stephenson M, Kasatkina M, Dax EM. Testing strategy development in HCV serology [abstract]. Australian Society of Microbiology Annual Scientific Meeting, Melbourne, Australia, October 26-November 1, 1997, A86.